
Sign up to save your podcasts
Or
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines
4.3
106106 ratings
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines
496 Listeners
38 Listeners
9 Listeners
18 Listeners
19 Listeners
14 Listeners
11 Listeners
5 Listeners
7 Listeners
9 Listeners
21 Listeners
90 Listeners
5 Listeners
29 Listeners
14 Listeners
5 Listeners
20 Listeners
2 Listeners
163 Listeners